Hutch News
Results per Page:
Test of a new 'germline-targeting' HIV vaccine prepares to launch
Vaccine’s unique protein designed to start process of building powerful antibodies against AIDS virus
What Hutch coronavirus experts are saying about omicron
Some answers, but many questions, about highly mutated new variant of COVID-19 virus
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
World AIDS Day 2021: Let's give the gifts of hope and focus to HIV research
HIV scientific infrastructure paved the way for the world’s COVID-19 response. Now, it’s time to return the favor.
Tip Sheet: Making clinical trials more inclusive, measuring COVID vaccine protection and new HIV vaccine results
Summaries of recent Fred Hutch research findings and other news
New concerns about coronavirus evolution in immunosuppressed patients
Experts call for tighter precautions, better treatments, more research
Tip Sheet: Massive unmet needs in COVID-19 treatment, osteoporosis drugs for breast cancer, new bladder cancer target — and AIDS at 40
Summaries of recent Fred Hutch research findings and other news
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Dr. Larry Corey receives public service award from American Society of Gene & Cell Therapy
Sonia Skarlatos Public Service Award recognizes person who has advanced field of gene and cell therapy
Tip Sheet: New COVID-19 transmission study, returning to school, video of biorepositories — and a new weight loss study
Summaries of recent Fred Hutch research findings and other news
College students muster for big COVID-19 vaccine study
12,000 participants sought in study to prove if vaccine can block asymptomatic transmission
5 reasons why a cancer research center has virology expertise
Pathogens can cause diseases, the immune system can fight them
HIV antibody trial results offer 'proof of concept'
Outcome of AMP shows feasibility of developing potent antibody combinations to block HIV
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Community engagement in HIV trials guides equity for COVID-19 vaccine studies
New study highlights longstanding barriers to diversity in prior decade of vaccine trials, despite federal guidelines
Biostatisticians draft blueprints for COVID-19 vax trials
Hutch group applies skills honed during decades of HIV prevention trials to bring about safe and effective vaccines for a new pandemic
Tip Sheet: COVID-19 vaccines, SARS-CoV-2 mutations, shedding pandemic pounds – and nematode nerve cells
Summaries of recent Fred Hutch research findings and other news
Scientists predict progress against COVID-19, cancer in 2021
After a challenging and deadly 2020, some hopeful predictions for the new year
A year of research dominated by the coronavirus
Scientists applied diverse expertise to pandemic in 2020 while advancing discoveries and cures for cancer